Investors

Press Releases

Overview
Press Releases
Events + Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
News Alerts

Recent Press Releases

Enveric Biosciences and MagicMed to Participate in June 2021 Investor and Industry Conferences
June 03, 2021

Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
May 24, 2021

Enveric Biosciences Reports First Quarter 2021 Financial Results
May 18, 2021

Enveric Biosciences Appoints Dr. Arash Asher to Scientific Advisory Board
May 12, 2021

Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st
April 14, 2021

Enveric Biosciences Appoints Carter Ward as Chief Financial Officer
April 12, 2021

Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021
April 01, 2021

Enveric Biosciences Appoints Dr. Douglas D. Lind to Company's Board of Directors
March 18, 2021

Enveric Biosciences to Participate in Upcoming Investor Conferences in March
March 15, 2021

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech
March 10, 2021

Enveric Newsroom